X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-04-08 | BRTX | Biorestorative Therapies, Inc. | Silva Francisco | VP of Research, Development | P - Purchase | $1.23 | +8,308 | 167,895 | +5% | +$10,229 | |||||
| D | 2024-04-01 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $37.52 | -1,000 | 83,631 | -1% | -$37,523 | |||||
| D | 2024-04-01 | PGNY | Progyny, Inc. | Sturmer Michael E | Pres | S - Sale+OE | $37.60 | -6,395 | 384,553 | -2% | -$240,452 | |||||
| D | 2024-04-01 | PGNY | Progyny, Inc. | Livingston Mark S. | CFO | S - Sale+OE | $37.62 | -11,165 | 50,119 | -18% | -$419,979 | |||||
| D | 2024-03-27 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $37.80 | -71,272 | 86,312 | -45% | -$2,694,267 | |||||
| DM | 2024-03-25 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $37.63 | -2,902 | 86,312 | -3% | -$109,217 | |||||
| D | 2024-03-21 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $37.74 | -5,826 | 86,312 | -6% | -$219,877 | |||||
2024-03-14 | AGL | Agilon Health, Inc. | Kornitzer Benjamin | Chief Med., Quality Officer | P - Purchase | $0.00 | +5,434 | 62,058 | +10% | +$0 | ||||||
2024-03-14 | AGL | Agilon Health, Inc. | Venkatachaliah Girish | CTO | P - Purchase | $0.00 | +5,434 | 39,950 | +16% | +$0 | ||||||
2024-03-14 | AGL | Agilon Health, Inc. | Shaker Benjamin | Chief Markets Officer | P - Purchase | $0.00 | +274,455 | 258,732 | -1746% | +$0 | ||||||
2024-03-14 | AGL | Agilon Health, Inc. | Desai Veeral | Chief Strategy, Dev. Officer | P - Purchase | $0.00 | +11,956 | 306,641 | +4% | +$0 | ||||||
2024-03-14 | AGL | Agilon Health, Inc. | Bensley Timothy | CFO | P - Purchase | $0.00 | +14,945 | 43,365 | +53% | +$0 | ||||||
2024-03-07 | MRAI | Marpai, Inc. | Lamendola Damien | CEO, 10% | P - Purchase | $1.65 | +910,000 | 3,992,980 | +30% | +$1,501,500 | ||||||
2024-03-04 | SHC | Sotera Health Co | Warburg Pincus & Co. | Dir, 10% | S - Sale | $14.31 | -16,594,363 | 88,822,952 | -16% | -$237,423,849 | ||||||
2024-03-04 | SHC | Sotera Health Co | Warburg Pincus & Co. | Dir, 10% | S - Sale | $14.31 | -16,594,363 | 88,822,952 | -16% | -$237,423,849 | ||||||
2024-03-04 | SHC | Sotera Health Co | Gtcr Investment Xi LLC | Dir, 10% | S - Sale | $14.31 | -11,062,908 | 59,215,301 | -16% | -$158,282,556 | ||||||
2024-03-04 | SHC | Sotera Health Co | Klee Ann R. | Dir | S - Sale | $14.31 | -5,750 | 86,735 | -6% | -$82,268 | ||||||
| D | 2024-03-04 | SHC | Sotera Health Co | Rutz Michael P | Pres of Sterigenics | S - Sale+OE | $14.31 | -83,109 | 544,409 | -13% | -$1,189,082 | |||||
| D | 2024-03-04 | SHC | Sotera Health Co | Petras Michael B. Jr. | COB, CEO | S - Sale+OE | $14.31 | -1,003,870 | 6,153,329 | -14% | -$14,362,870 | |||||
| D | 2024-03-01 | PGNY | Progyny, Inc. | Livingston Mark S. | CFO | S - Sale+OE | $36.64 | -12,610 | 37,360 | -25% | -$461,977 | |||||
2024-03-01 | PGNY | Progyny, Inc. | Sturmer Michael E | Pres | S - Sale | $36.63 | -11,009 | 140,948 | -7% | -$403,260 | ||||||
| DM | 2024-02-26 | DVA | Davita Inc. | Rodriguez Javier | CEO | S - Sale+OE | $126.18 | -75,000 | 494,480 | -13% | -$9,463,597 | |||||
| D | 2024-02-21 | DVA | Davita Inc. | Staffieri Michael David | COO, DKC | S - Sale+OE | $119.81 | -29,488 | 196,193 | -13% | -$3,533,025 | |||||
| D | 2024-02-21 | DVA | Davita Inc. | Waters Kathleen Alyce | Chief Legal, Pub. Affairs Off | S - Sale+OE | $120.73 | -11,285 | 81,297 | -12% | -$1,362,438 | |||||
| D | 2024-02-16 | DVA | Davita Inc. | Hearty James O | Chief Compliance Officer | S - Sale+OE | $119.64 | -26,164 | 20,264 | -56% | -$3,130,269 | |||||
| DM | 2024-02-08 | BRTX | Biorestorative Therapies, Inc. | Broadrick Dale | 10% | P - Purchase | $1.29 | +160,000 | 1,316,948 | +14% | +$206,023 | |||||
| DM | 2024-02-07 | BRTX | Biorestorative Therapies, Inc. | Broadrick Dale | 10% | P - Purchase | $1.35 | +120,000 | 765,017 | +19% | +$162,255 | |||||
2024-02-06 | PGNY | Progyny, Inc. | Sturmer Michael E | Pres | S - Sale | $40.00 | -2,260 | 158,532 | -1% | -$90,400 | ||||||
| D | 2024-02-05 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $38.50 | -20,000 | 86,312 | -19% | -$769,928 | |||||
| D | 2024-02-01 | PGNY | Progyny, Inc. | Livingston Mark S. | CFO | S - Sale+OE | $37.84 | -12,651 | 43,871 | -22% | -$478,767 | |||||
2024-02-01 | PGNY | Progyny, Inc. | Sturmer Michael E | Pres | S - Sale | $37.89 | -6,395 | 160,792 | -4% | -$242,307 | ||||||
| DM | 2024-02-01 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $38.60 | -60,000 | 86,312 | -41% | -$2,316,126 | |||||
2024-01-16 | MRAI | Marpai, Inc. | Lamendola Damien | CEO, 10% | P - Purchase | $0.92 | +1,100,000 | 3,082,980 | +55% | +$1,012,110 | ||||||
2024-01-16 | MRAI | Marpai, Inc. | Pons Robert M | Dir | P - Purchase | $0.92 | +12,100 | 74,200 | +19% | +$11,133 | ||||||
2024-01-16 | MRAI | Marpai, Inc. | Eitan Yaron | Dir | P - Purchase | $0.92 | +210,000 | 601,454 | +54% | +$193,221 | ||||||
| D | 2024-01-08 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $37.88 | -66,002 | 86,312 | -43% | -$2,500,156 | |||||
| D | 2024-01-02 | PGNY | Progyny, Inc. | Livingston Mark S. | CFO | S - Sale+OE | $36.59 | -12,368 | 46,871 | -21% | -$452,540 | |||||
2024-01-02 | PGNY | Progyny, Inc. | Sturmer Michael E | Pres | S - Sale | $36.81 | -6,395 | 167,187 | -4% | -$235,400 | ||||||
| D | 2024-01-02 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $37.58 | -13,998 | 86,312 | -14% | -$526,024 | |||||
| DM | 2023-12-26 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $37.80 | -156,031 | 88,439 | -64% | -$5,898,285 | |||||
| DM | 2023-12-20 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $37.87 | -162,906 | 88,439 | -65% | -$6,169,347 | |||||
| D | 2023-12-14 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $37.53 | -1,063 | 88,439 | -1% | -$39,894 | |||||
2023-12-14 | MRAI | Marpai, Inc. | Lamendola Damien | CEO, 10% | P - Purchase | $1.97 | +150,000 | 1,982,980 | +8% | +$295,500 | ||||||
2023-12-14 | MRAI | Marpai, Inc. | Pons Robert M | Dir | P - Purchase | $1.81 | +12,100 | 12,100 | New | +$21,901 | ||||||
2023-12-14 | MRAI | Marpai, Inc. | Eitan Yaron | Dir | P - Purchase | $1.97 | +50,000 | 391,454 | +15% | +$98,500 | ||||||
2023-12-11 | PGNY | Progyny, Inc. | Gordon Kevin K | Dir | S - Sale | $35.93 | -2,500 | 9,854 | -20% | -$89,825 | ||||||
2023-12-01 | PGNY | Progyny, Inc. | Sturmer Michael E | Pres | S - Sale | $34.13 | -12,696 | 173,582 | -7% | -$433,314 | ||||||
| D | 2023-12-01 | PGNY | Progyny, Inc. | Livingston Mark S. | CFO | S - Sale+OE | $34.62 | -25,087 | 49,983 | -33% | -$868,512 | |||||
| D | 2023-12-01 | BRTX | Biorestorative Therapies, Inc. | Broadrick Dale | 10% | S - Sale+OE | $1.88 | -250 | 645,017 | 0% | -$469 | |||||
| D | 2023-11-27 | BRTX | Biorestorative Therapies, Inc. | Broadrick Dale | 10% | S - Sale+OE | $1.89 | -278 | 645,267 | 0% | -$525 | |||||
2023-11-29 | AGL | Agilon Health, Inc. | Schwaneke Jeffrey A. | Dir | P - Purchase | $11.22 | +22,300 | 31,931 | +232% | +$250,206 | ||||||
2023-11-21 | MRAI | Marpai, Inc. | Lamendola Damien | CEO, 10% | P - Purchase | $1.19 | +200,000 | 1,832,980 | +12% | +$238,680 | ||||||
2023-11-17 | MRAI | Marpai, Inc. | Eitan Yaron | Dir | P - Purchase | $1.23 | +100,000 | 341,454 | +41% | +$123,000 | ||||||
| D | 2023-10-02 | PFHO | Pacific Health Care Organization Inc | Kubota Tom | CEO, Pres, 10% | P - Purchase | $0.80 | +55,000 | 8,351,647 | +1% | +$44,000 | |||||
| DM | 2023-09-26 | PFHO | Pacific Health Care Organization Inc | Kubota Tom | CEO, Pres, 10% | P - Purchase | $0.85 | +25,000 | 8,296,647 | 0% | +$21,250 | |||||
| D | 2023-09-22 | PFHO | Pacific Health Care Organization Inc | Kubota Tom | CEO, Pres, 10% | P - Purchase | $0.82 | +400 | 8,271,647 | 0% | +$328 | |||||
| DM | 2023-09-12 | AGL | Agilon Health, Inc. | Shaker Benjamin | Chief Markets Officer | S - Sale+OE | $18.03 | -37,500 | 79,543 | -32% | -$675,936 | |||||
| DM | 2023-07-28 | BRTX | Biorestorative Therapies, Inc. | Broadrick Dale | 10% | P - Purchase | $2.07 | +2,500 | 625,545 | 0% | +$5,165 | |||||
| D | 2023-09-11 | AGL | Agilon Health, Inc. | Gertsch Timothy | Chief Accounting Officer | S - Sale+OE | $18.61 | -26,250 | 17,121 | -61% | -$488,616 | |||||
| D | 2023-09-13 | BRTX | Biorestorative Therapies, Inc. | Alstodt Lance | Pres, CEO, COB, 10% | P - Purchase | $1.53 | +800 | 188,105 | 0% | +$1,226 | |||||
| D | 2023-09-12 | PFHO | Pacific Health Care Organization Inc | Kubota Tom | CEO, Pres, 10% | P - Purchase | $0.82 | +200 | 8,271,247 | 0% | +$164 | |||||
| D | 2023-09-11 | PFHO | Pacific Health Care Organization Inc | Kubota Tom | CEO, Pres, 10% | P - Purchase | $0.82 | +54,047 | 8,271,047 | +1% | +$44,319 | |||||
2023-09-11 | MRAI | Marpai, Inc. | Gonzalez Edmundo | CEO | P - Purchase | $0.77 | +42,000 | 342,325 | +14% | +$32,340 | ||||||
| D | 2023-09-07 | PFHO | Pacific Health Care Organization Inc | Kubota Tom | CEO, Pres, 10% | P - Purchase | $0.85 | +61,000 | 8,217,000 | +1% | +$51,850 | |||||
| D | 2023-09-06 | BRTX | Biorestorative Therapies, Inc. | Alstodt Lance | Pres, CEO, COB, 10% | P - Purchase | $1.96 | +2,887 | 187,305 | +2% | +$5,659 | |||||
| D | 2023-08-30 | PFHO | Pacific Health Care Organization Inc | Kubota Tom | CEO, Pres, 10% | P - Purchase | $0.90 | +31,000 | 8,156,000 | 0% | +$27,900 | |||||
| D | 2023-08-31 | BRTX | Biorestorative Therapies, Inc. | Silva Francisco | VP of Research, Development, 10% | P - Purchase | $2.22 | +4,954 | 176,780 | +3% | +$10,998 | |||||
| D | 2023-08-22 | DVA | Davita Inc. | Waters Kathleen Alyce | Chief Legal, Pub. Affairs Off | S - Sale+OE | $101.81 | -9,794 | 81,297 | -11% | -$997,099 | |||||
| DM | 2023-08-14 | AGL | Agilon Health, Inc. | Shaker Benjamin | Chief Markets Officer | S - Sale+OE | $18.41 | -37,500 | 79,543 | -32% | -$690,392 | |||||
2023-08-07 | PGNY | Progyny, Inc. | Tpg Gp A, LLC | Former 10% Owner | S - Sale | $41.08 | -2,900,000 | 6,350,000 | -31% | -$119,132,000 | ||||||
| D | 2023-07-27 | BRTX | Biorestorative Therapies, Inc. | Broadrick Dale | 10% | P - Purchase | $2.80 | +1,000 | 306,073 | 0% | +$2,800 | |||||
| D | 2023-07-25 | BRTX | Biorestorative Therapies, Inc. | Alstodt Lance | Pres, CEO, COB, 10% | P - Purchase | $2.44 | +4,200 | 184,418 | +2% | +$10,248 | |||||
| D | 2023-07-14 | PGNY | Progyny, Inc. | Anevski Peter | CEO | S - Sale+OE | $38.95 | -20,086 | 207,948 | -9% | -$782,350 | |||||
| DM | 2023-07-12 | AGL | Agilon Health, Inc. | Shaker Benjamin | Chief Markets Officer | S - Sale+OE | $16.95 | -37,500 | 79,543 | -32% | -$635,606 | |||||
| DM | 2023-07-12 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $38.84 | -106,144 | 70,806 | -60% | -$4,122,316 | |||||
| DM | 2023-07-12 | PGNY | Progyny, Inc. | Anevski Peter | CEO | S - Sale+OE | $38.82 | -68,462 | 210,044 | -25% | -$2,657,372 | |||||
2023-06-27 | PGNY | Progyny, Inc. | Scott Cheryl | Dir | S - Sale | $37.27 | -1,170 | 9,744 | -11% | -$43,606 | ||||||
| D | 2023-07-03 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $38.76 | -18,856 | 73,487 | -20% | -$730,859 | |||||
| D | 2023-07-03 | PGNY | Progyny, Inc. | Anevski Peter | CEO | S - Sale+OE | $38.78 | -8,049 | 230,911 | -3% | -$312,140 | |||||
2023-06-21 | MRAI | Marpai, Inc. | Gonzalez Edmundo | CEO | P - Purchase | $0.51 | +20,000 | 1,201,299 | +2% | +$10,102 | ||||||
| D | 2023-06-20 | PFHO | Pacific Health Care Organization Inc | Kubota Tom | CEO, Pres, 10% | P - Purchase | $0.87 | +37,000 | 8,125,000 | 0% | +$32,250 | |||||
| DM | 2023-06-14 | AGL | Agilon Health, Inc. | Shaker Benjamin | Chief Markets Officer | S - Sale+OE | $18.65 | -37,500 | 79,543 | -32% | -$699,249 | |||||
| D | 2023-06-14 | VMD | Viemed Healthcare, Inc. | Smokoff Timothy | Dir | S - Sale+OE | $13.51 | -10,361 | 67,332 | -13% | -$139,977 | |||||
| D | 2023-06-07 | PGNY | Progyny, Inc. | Anevski Peter | CEO | S - Sale+OE | $40.97 | -20,000 | 232,521 | -8% | -$819,389 | |||||
| D | 2023-06-05 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $40.00 | -41,666 | 73,487 | -36% | -$1,666,824 | |||||
| DM | 2023-06-05 | PGNY | Progyny, Inc. | Anevski Peter | CEO | S - Sale+OE | $40.50 | -40,000 | 236,521 | -14% | -$1,620,178 | |||||
| DM | 2023-06-01 | PGNY | Progyny, Inc. | Anevski Peter | CEO | S - Sale+OE | $38.11 | -40,000 | 244,521 | -14% | -$1,524,463 | |||||
| DM | 2023-06-01 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $38.11 | -83,334 | 73,487 | -53% | -$3,176,111 | |||||
| D | 2023-05-24 | PGNY | Progyny, Inc. | Gordon Kevin K | Dir | S - Sale+OE | $38.24 | -1,410 | 12,354 | -10% | -$53,918 | |||||
| D | 2023-05-16 | PGNY | Progyny, Inc. | Anevski Peter | CEO | S - Sale+OE | $35.94 | -5,761 | 252,521 | -2% | -$207,050 | |||||
| A | 2023-05-09 | PGNY | Progyny, Inc. | Anevski Peter | CEO | S - Sale | $37.74 | -7,663 | 69,750 | -10% | -$289,193 | |||||
2023-05-18 | AGL | Agilon Health, Inc. | Cd&R Investment Associates Ix, Ltd. | 10% | S - Sale | $20.80 | -94,173,804 | 100,000,000 | -48% | -$1,958,937,549 | ||||||
| DM | 2023-05-15 | AGL | Agilon Health, Inc. | Shaker Benjamin | Chief Markets Officer | S - Sale+OE | $23.47 | -50,000 | 79,543 | -39% | -$1,173,268 | |||||
| DM | 2023-05-12 | PGNY | Progyny, Inc. | Anevski Peter | CEO | S - Sale+OE | $36.27 | -80,000 | 247,579 | -24% | -$2,901,600 | |||||
| D | 2023-05-12 | DVA | Davita Inc. | Yale Phyllis R | Dir | S - Sale+OE | $95.26 | -2,196 | 13,110 | -14% | -$209,195 | |||||
| D | 2023-05-10 | DVA | Davita Inc. | Rodriguez Javier | CEO | S - Sale+OE | $99.44 | -16,916 | 374,402 | -4% | -$1,682,089 | |||||
| D | 2023-05-10 | DVA | Davita Inc. | Waters Kathleen Alyce | Chief Legal, Pub. Affairs Off | S - Sale+OE | $99.24 | -15,941 | 91,245 | -15% | -$1,581,990 | |||||
| D | 2023-05-10 | DVA | Davita Inc. | Hearty James O | Chief Compliance Officer | S - Sale+OE | $101.64 | -5,745 | 32,559 | -15% | -$583,914 | |||||
| D | 2023-05-10 | DVA | Davita Inc. | Desoer Barbara J | Dir | S - Sale+OE | $101.61 | -2,449 | 14,098 | -15% | -$248,843 | |||||
| D | 2023-05-10 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | S - Sale+OE | $37.72 | -34,593 | 73,487 | -32% | -$1,304,978 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |